Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Propose...(of the SERENADE study in the European la...),Health

November 19, 2007 Announcement of FDA approval for Avalide(R)

(irbesartan, hydrochlorothiazide) as the

first combination therapy for initial use in

patients likely to need multiple drugs to

achieve blood pressure goals

November 26, 2007 Announcement of the signature in Beijing of

an agreement between the Chinese authorities

and sanofi-aventis to build a facility to

manufacture influenza vaccine in China

November 29, 2007 Announcement of the signature of a global,

strategic collaboration agreement with

Regeneron to discover, develop, and

commercialize fully-human therapeutic

antibodies utilizing Regeneron's proprietary

VelociSuite of technologies

November 30, 2007 Announcement by sanofi-aventis and Astellas

of an agreement to restructure their joint

venture activities in Japan (Fujisawa

sanofi-aventis K.K.)

December 3, 2007 Inauguration by sanofi-aventis of its first

Asian development centre for

pharmaceuticals, in Goa (India)

December 10, 2007 Presentation to the American Society of

Hematology (ASH) of the results of the TREK

dose-ranging study on AVE5026 (a new

injectable anticoagulant), demonstrating a

highly statistically significant dose

response

December 13, 2007 Oral Presentation of the US Oncology

'/>"/>